DavangerePDevanandMDMBBS

PubMed

• Exploring the role of T cells in Alzheimer's and other neurodegenerative diseases: Emerging therapeutic insights from the T Cells in the Brain symposium.
  Wassim Elyaman, Lawrence J Stern, Ning Jiang, Dallin Dressman, Philip Bradley
  Alzheimer's & Dementia. 2025-01-27
• Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity Conference.
  Courtney M Kloske, Simin Mahinrad, Christopher J Barnum, Andre F Batista, Elizabeth M Bradshaw
  Alzheimer's & Dementia. 2025-01-01
• Depression, Anxiety, and Neuropsychiatric Symptom Burden in a Longitudinal Cohort with Persistent Psychophysical Post-COVID Olfactory Dysfunction.
  Tiana M Saak, Jeremy P Tervo, Brandon J Vilarello, Patricia T Jacobson, Francesco F Caruana
  Brain Sciences. 2024-12-19

Journal Articles

• Age-Specific Prevalence and Incidence of Dementia Diagnoses Among Older US Adults with Schizophrenia  
  Mark Olfson, Davangere P Devanand, JAMA Psychiatry
• Odor Identification Ability Predicts PET Amyloid Status and Memory Decline in Older Adults  
  Kreisl WC, Jin P, Lee S, Dayan ER, Vallabhajosula S, Pelton G, Luchsinger JA, Pradhaban G, Devanand DP., J Alzheimers Dis, 1/1/2018
• A Link between Subjective Perceptions of Memory and Physical Function: Implications for Subjective Cognitive Decline  
  Cosentino S, Devanand DP, Gurland B., J Alzheimers Dis., 1/1/2018
• Impaired Identification of Specific Odors and Cognition in Older Adults  
  Devanand DP, Am J Geriatr Psychiatry, 1/1/2018
•  
  Gulisano W, Maugeri D, Baltrons MA, F� M, Amato A, Palmeri A, D'Adamio L, Grassi C, Devanand DP, Honig LS, Puzzo D, Arancio O., J Alzheimers Dis, 1/1/2018
• Association of Obstructive Sleep Apnea with Episodic Memory and Cerebral Microvascular Pathology: A Preliminary Study  
  Kerner NA, Roose SP, Pelton GH, Ciarleglio A, Scodes J, Lentz C, Sneed JR, Devanand DP., Am J Geriatr Psychiatry., 1/1/2017
• Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series  
  Devanand DP, Pelton GH, D'Antonio K, Strickler JG, Kreisl WC, Noble J, Marder K, Skomorowsky A, Huey ED, Alzheimer Dis Assoc Disord., 1/1/2017
• Brain Regions Involved in Arousal and Reward Processing are Associated with Apathy in Alzheimer's Disease and Frontotemporal Dementia  
  Huey ED, Lee S, Cheran G, Grafman J, Devanand DP; Alzheimer�s Disease Neuroimaging Initiative., J Alzheimers Dis., 1/1/2017
• Prediction of Response to Antipsychotics in Patients with Dementia Remains a Conundrum  
  Devanand DP, Am J Geriatr Psychiatry., 1/1/2017
• Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment  
  Devanand DP, Lentz C, Chunga RE, Ciarleglio A, Scodes JM, Andrews H, Schofield PW, Stern Y, Huey ED, Bell K, Pelton GH., J Alzheimers Dis., 1/1/2017
• Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition  
  Reijs BLR, Ramakers IHGB, Elias-Sonnenschein L, Teunissen CE, Koel-Simmelink M, Tsolaki M, Wahlund LO, Waldemar G, Hausner L, Johannsen P, Vanderstichele H, Verhey F, ..., J Alzheimers Dis., 1/1/2017
• Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia  
  Lan MJ, Ogden RT, Kumar D, Stern Y, Parsey RV, Pelton GH, Rubin-Falcone H, Pradhaban G, Zanderigo F, Miller JM, Mann JJ, Devanand DP., J Alzheimers Dis, 1/1/2017
• Combined memantine/escitalopram treatment of patients with depression and cognitive impairment: a pilot study  
  Pelton GH, Harper OL, Roose SP, Marker KS, Devanand DP, International Journal of Geriatric Psychiatry, 1/1/2016
• Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial  
  Luchsinger JA, Perez T, Chang H, Mehta P, Steffener J, Pradabhan G, Ichise M, Manly J, Devanand DP, Bagiella E, J Alzheimers Dis., 1/1/2016
• R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation  
  Ho T, Pollock BG, Mulsant BH, Schantz O, Devanand DP, Mintzer JE, Porsteinsson AP, Schneider LS, Weintraub D, Yesavage J, Drye LT, Munro CA, Shade DM, Lyketsos C, Bies R, Br J Clin Pharmacol., 1/1/2016
• Olfactory Identification Deficits, Cognitive Decline, and Dementia in Older Adults  
  Devanand DP., Am J Geriatr Psychiatry, 1/1/2016
• At the interface of sensory and motor dysfunctions and Alzheimer�s disease  
  Albers MW, Gilmore GC, Kaye J, Murphy C, Wingfield A, Bennett DA, Boxer AL, Buchman AS, Cruickshanks KJ, Devanand DP, Duffy CJ, Gall CM, Gates GA, Granholm A-C, Hensch..., Alzheimer�s and Dementia, 1/1/2015
• Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition  
  Cummings J, Mintzer J, Brodaty H, Sano M, Banerjee S, Devanand DP, Gauthier S, Howard R, Lanct�t K, Lyketsos CG, Peskind E, Porsteinsson AP, Reich E, Sampaio C, Steffe..., International Psychogeriatrics, 1/1/2015
• Olfactory deficits predict cognitive decline and Alzheimer�s dementia in an urban community  
  Devanand DP, Lee S, Manly JJ, Andrews HA, Schupf N, Doty RL, Stern Y, Zahodne LB, Louis E, Mayeux R, Neurology, 1/1/2015
• Longitudinal relationships between Alzheimer�s disease progression and psychosis, depressed mood and agitation/aggression  
  Zahodne LB, Ornstein K, Cosentino S, Devanand DP, and Stern Y., American Journal of Geriatric Psychiatry, 1/1/2015
• Lithium treatment and risk for dementia in adults with bipolar disorder: population-based cohort study  
  Gerhard T, Devanand DP, Huang C, Crystal S, Olfson M, British Journal of Psychiatry, 1/1/2015
• Brain amyloid deposition and longitudinal cognitive decline in non-demented older subjects: results from a multi-ethnic population  
  Gu Y, Razlighi QR, Zahodne LB, Janicki SC, Ichise M, Manly JJ, Devanand DP, Brickman AM, Schupf N, Mayeux R, Stern Y., Plos One, 1/1/2015
• Olfactory identification deficits and increased mortality in the community  
  Devanand DP, Lee S, Manly J, Andrews H, Schupf N, Masurkar A, Stern Y, Mayeux R, Doty RL, Annals of Neurology, 1/1/2015
• Olfactory deficits in normal aging, cognitive decline and Alzheimer�s disease What do they mean for research and practice?  
  Devanand DP, International Psychogeriatrics Association Bulletin, 1/1/2015
• Comparative mortality risks of antipsychotic medications in community-dwelling older adults  
  Gerhard T, Huybrechts K, Olfson M, Schneeweiss S, Bobo WV, Doraiswamy PM, Devanand DP, Lucas JA, Huang C, Malka ES, Levin R, and Crystal S., British Journal of Psychiatry, 1/1/2014
• Join now to see all

Books/Book Chapters

• Comprehensive Textbook of Psychiatry 
  Chapter: Psychiatric Assessment of the Older Patient. 
  Page 3971. - 3977.Devanand DP and Pelton GHEditors: Sadock BI, Sadock VI, Ruiz P.Wolters Kluwer Health; Lipincott, Williams and Wilkins, PhiladelphiaEdition Tent,2017
• Psychiatry 
  Chapter: Cognitive enhancers and treatments for Alzheimer�s disease. 
  Page 2236. - 2260.Devanand DPEditors: Tasman A, Kay J, Lieberman JA.John Wiley and Sons, New YorkEdition 4th,2015
• Clinical Handbook for the Management of Mood Disorders 
  Chapter: Treatment of mood disorders in late life. 
  Page 119.0 - 132.0Roose SP and Devanand DP.Editors: Mann JJ, McGrath PJ and Roose SP.Cambridge University Press, New York2013
• Textbook of Geriatric Neuropsychiatry 
  Chapter: Psychosis 
  Page 517.0 - 536.0Devanand DP.Editors: Coffey EC, Cummings JL, George MS, Weintraub D.American Psychiatric Publishing, IncEdition Thir,2011
• Principles and Practice of Geriatric Psychiatry 
  Chapter: Clinical Features of Depressive Disorders in the Elderly. 
  Page 495.0 - 501.0Devanand DP and Roose SP.Editors: Abou-Saleh MT, Katona C and Kumar A.John Wiley and SonsEdition 3rd,2011
• Textbook of Mood Disorders 
  Chapter: Geriatric Mood Disorders 
  Page 603.0 - 619.0Roose SP, Devanand DPEditors: Stein D, Kupfer DJ, Schatzberg AF.American Psychiatric Publishing, Washington, D.C.Edition Firs,2006
• Comprehensive Textbook of Psychiatry 
  Chapter: Psychiatric Assessment of the Older Patient 
  Page 3603. - 3610.Devanand DPEditors: Sadock BI and Sadock VI.Lipincott, Williams and Wilkins, PhiladelphiaEdition Eigh,2005
• Late-Life Depression 
  Chapter: Dysthymic Disorder in the Elderly. 
  Page 49.0 - 63.0Devanand DP.Editors: Roose SP, HA Sackeim HA.Oxford University Press, New York2004
• Textbook of Psychopharmacology 
  Chapter: Psychopharmacological treatment: treatment during late life. 
  Page 1083. - 1108.Roose SP, Pollock BG, Devanand DPEditors: Schatzberg AF, Nemeroff CB.American Psychiatric Publishing, Inc., Washington, D.C.2004
• Evidence-Based Dementia: a practical guide to diagnosis and management (with internet updates). 
  Chapter: Treatment of depression in patients with dementia 
  Page 695.0 - 698.0Devanand DP, Pelton GH, Roose SP.Editors: Qizilbash N, Schneider L, Chui H, Tariot P, Brodaty H, Kaye J, Erkinjutti T.Blackwell Science, London2002
• The Difficult-to-Treat Psychiatric Patient 
  Chapter: Special somatic treatments 
  Page 359.0 - 392.0Devanand DP, Lisanby SH, Sackeim HA.Editors: Dewan MJ, Pies RW.American Psychiatric Press, Washington, D.C.2001
• Alzheimer�s Disease and Related Disorders Annual 2001 
  Chapter: Depression in Dementia. 
  Page 97.0 - 122.0Devanand DPEditors: Gauthier S., Cummings J.L..Martin Dunitz, London2001
• The Memory Program 
  Devanand DPJohn Wiley and Sons, New York2001
• Pharmacotherapy for mood, anxiety and cognitive disorders 
  Chapter: Electroconvulsive Therapy: current practice and future directions 
  Page 167.0 - 188.0Nobler MS, Sackeim HA, Devanand DPEditors: Halbreich U and Montgomery SA.American Psychiatric Press, Washington, D.C.2000
• Treatment of Behavioral and Psychological Symptoms of Dementia 
  Devanand DP and Lawlor BMartin Dunitz, London2000
• The Interface between Depression and Dementia 
  Roose SP and Devanand DPMartin Dunitz, London1998
• Geriatric Psychopharmacology 
  Chapter: Neuroleptics for behavioral complications of dementia. 
  Page 405.0 - 425.0Devanand DPEditors: Nelson JC.Marcel Dekker, Inc., New York1997
• Behavioral Complications in Alzheimer's disease 
  Chapter: Role of neuroleptics in treatment of behavioral complications 
  Page 131.0 - 151.0Devanand DPEditors: Lawlor, B.A..American Psychiatric Press, Inc., Washington, D.C.1995
• Psychopharmacology: The Fourth Generation of Progress. 
  Chapter: Electroconvulsive Therapy. 
  Page 1123. - 1141.Sackeim HA, Devanand DP, and Nobler MSEditors: Bloom F and Kupfer D.Raven Press, New York1995
• The Columbia University College of Physicians and Surgeons Complete Home Guide to Mental Health 
  Chapter: Alzheimer's disease and other organic causes of mental disorders 
  Page 206.0 - 220.0Devanand DP and Mayeux R.Editors: Kass F, Oldham J, and Pardes H.Henry Holt & Co, New York1992
• Adult Psychopathology and Diagnosis 
  Chapter: Dissociative disorders 
  Page 279.0 - 322.0Sackeim HA, and Devanand DPEditors: Hersen M and Turner SM.Wiley, New YorkEdition Seco,1991
• Annual Review of Psychiatry 
  Chapter: Treatment of medication-resistant depression with electroconvulsive therapy. 
  Page 91.0 - 115.0Sackeim HA, Prudic J, and Devanand DP.Editors: Tasman A, Goldfinger SM, and Kaufmann CA.American Psychiatric Press, Washington, D.C.1990
• The Biological Basis of Psychiatric Treatment 
  Chapter: Electroconvulsive Therapy. 
  Page 170.0 - 210.0Devanand DP, and Sackeim HAEditors: Pohl R and Gershon S.Karger Publications, Basel1990
• Join now to see all

Other

• Comparing three methods of computerized cognitive training for older adults with subclinical cognitive decline. 
  Gooding AL, Choi J, Fiszdon JM, Wilkins K, Kirwin PD, van Dyck CH, Devanand DP, Bell MD & Mindt MR, Neuropsychological Rehabilitation
  http://www.tandfonline.com/loi/pnrh20